Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.authorBurr, Jennifer M.
dc.contributor.authorCampbell, Marion K.
dc.contributor.authorCampbell, Susan E.
dc.contributor.authorFrancis, Jillian J.
dc.contributor.authorGreene, Alexandra
dc.contributor.authorHernandez, Rodolfo
dc.contributor.authorHopkins, Debra
dc.contributor.authorMcCann, Sharon K.
dc.contributor.authorVale, Luke D.
dc.contributor.authorGlaucoma Screening Platform Study
dc.date.accessioned2012-03-02T15:01:02Z
dc.date.available2012-03-02T15:01:02Z
dc.date.issued2011-04-21
dc.identifier.citationBurr , J M , Campbell , M K , Campbell , S E , Francis , J J , Greene , A , Hernandez , R , Hopkins , D , McCann , S K , Vale , L D & Glaucoma Screening Platform Study 2011 , ' Developing the clinical components of a complex intervention for a glaucoma screening trial : a mixed methods study ' , BMC Medical Research Methodology , vol. 11 , 54 . https://doi.org/10.1186/1471-2288-11-54en
dc.identifier.issn1471-2288
dc.identifier.otherPURE: 16572753
dc.identifier.otherPURE UUID: f1c53d20-0ef4-4a0f-8408-2dfcc1179668
dc.identifier.otherWOS: 000291530000001
dc.identifier.otherScopus: 79958851290
dc.identifier.otherORCID: /0000-0002-9478-738X/work/60196197
dc.identifier.urihttps://hdl.handle.net/10023/2395
dc.descriptionThis paper was developed from the first phase of a project funded by the Medical Research Council (project reference G0701759) Developing the intervention & outcome components of a proposed randomised controlled trial of screening for open angle glaucoma. The Health Services Research Unit and the Health Economics Research Unit are both core funded by the Chief Scientist Office of the Scottish Government Health Directorates.en
dc.description.abstractBackground: Glaucoma is a leading cause of avoidable blindness worldwide. Open angle glaucoma is the most common type of glaucoma. No randomised controlled trials have been conducted evaluating the effectiveness of glaucoma screening for reducing sight loss. It is unclear what the most appropriate intervention to be evaluated in any glaucoma screening trial would be. The purpose of this study was to develop the clinical components of an intervention for evaluation in a glaucoma (open angle) screening trial that would be feasible and acceptable in a UK eye-care service. Methods: A mixed-methods study, based on the Medical Research Council (MRC) framework for complex interventions, integrating qualitative (semi-structured interviews with 46 UK eye-care providers, policy makers and health service commissioners), and quantitative (economic modelling) methods. Interview data were synthesised and used to revise the screening interventions compared within an existing economic model. Results: The qualitative data indicated broad based support for a glaucoma screening trial to take place in primary care, using ophthalmic trained technical assistants supported by optometry input. The precise location should be tailored to local circumstances. There was variability in opinion around the choice of screening test and target population. Integrating the interview findings with cost-effectiveness criteria reduced 189 potential components to a two test intervention including either optic nerve photography or screening mode perimetry (a measure of visual field sensitivity) with or without tonometry (a measure of intraocular pressure). It would be more cost-effective, and thus acceptable in a policy context, to target screening for open angle glaucoma to those at highest risk but for both practicality and equity arguments the optimal strategy was screening a general population cohort beginning at age forty. Conclusions: Interventions for screening for open angle glaucoma that would be feasible from a service delivery perspective were identified. Integration within an economic modelling framework explicitly highlighted the trade-off between cost-effectiveness, feasibility and equity. This study exemplifies the MRC recommendation to integrate qualitative and quantitative methods in developing complex interventions. The next step in the development pathway should encompass the views of service users.
dc.format.extent10
dc.language.isoeng
dc.relation.ispartofBMC Medical Research Methodologyen
dc.rights© 2011 The Glaucoma screening Platform Study group; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly citeden
dc.subjectOpen-angle glaucomaen
dc.subjectDiabetic-Retinopathyen
dc.subjectOcular hypertensionen
dc.subjectCost-effectivenessen
dc.subjectProgramen
dc.subjectMetaanalysisen
dc.subjectServiceen
dc.subjectPeopleen
dc.subjectRE Ophthalmologyen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subject.lccREen
dc.titleDeveloping the clinical components of a complex intervention for a glaucoma screening trial : a mixed methods studyen
dc.typeJournal articleen
dc.description.versionPublisher PDFen
dc.contributor.institutionUniversity of St Andrews. School of Medicineen
dc.identifier.doihttps://doi.org/10.1186/1471-2288-11-54
dc.description.statusPeer revieweden


This item appears in the following Collection(s)

Show simple item record